College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, 712100, China.
Department of Orthopedics, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200240, China.
Adv Sci (Weinh). 2023 Jun;10(17):e2206826. doi: 10.1002/advs.202206826. Epub 2023 Apr 21.
The amino acid-stimulated Rag GTPase pathway is one of the main pathways that regulate mechanistic target of rapamycin complex 1 (mTORC1) activation and function, but little is known about the effects of growth factors on Rag GTPase-mediated mTORC1 activation. Here, a highly conserved insulin-responsive phosphorylation site on folliculin (FLCN), Ser62, that is phosphorylates by AKT1 is identified and characterized. mTORC2-AKT1 is localized on lysosomes, and RagD-specific recruitment of mTORC2-AKT1 on lysosomes is identified as an essential step in insulin-AKT1-mediated FLCN phosphorylation. Additionally, FLCN phosphorylation inhibits the activity of RagC GTPase and is essential for insulin-induced mTORC1 activation. Functionally, phosphorylated FLCN promotes cell viability and induces autophagy, and also regulates in vivo tumor growth in an mTORC1-dependent manner. Its expression is also positively correlated with mTORC1 activity in colon cancer, clear cell renal cell carcinoma, and chordoma. These results indicate that FLCN is an important intermediate for cross-talk between the amino acid and growth factor pathways. Further, FLCN phosphorylation may be a promising therapeutic target for diseases characterized by mTORC1 dysregulation.
氨基酸刺激的 Rag GTPase 通路是调节雷帕霉素靶蛋白复合物 1(mTORC1)激活和功能的主要通路之一,但对于生长因子对 Rag GTPase 介导的 mTORC1 激活的影响知之甚少。在这里,鉴定并表征了成纤维细胞生长因子受体底物 2(FLCN)上一个高度保守的、受胰岛素响应的磷酸化位点丝氨酸 62(Ser62),该位点可被 AKT1 磷酸化。mTORC2-AKT1 定位于溶酶体上,RagD 特异性募集 mTORC2-AKT1 到溶酶体被鉴定为胰岛素-AKT1 介导的 FLCN 磷酸化的一个必需步骤。此外,FLCN 磷酸化抑制 RagC GTPase 的活性,是胰岛素诱导的 mTORC1 激活所必需的。在功能上,磷酸化的 FLCN 促进细胞活力并诱导自噬,并且以 mTORC1 依赖性方式调节体内肿瘤生长。其表达也与结肠癌、透明细胞肾细胞癌和脊索瘤中的 mTORC1 活性呈正相关。这些结果表明,FLCN 是氨基酸和生长因子通路之间串扰的一个重要中间物。此外,FLCN 磷酸化可能是 mTORC1 失调相关疾病的一个有前途的治疗靶点。